We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
-3.67%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$40.3B
AUM Growth
-$1.82B
Cap. Flow
+$332M
Cap. Flow %
0.83%
Top 10 Hldgs %
25.24%
Holding
2,393
New
237
Increased
785
Reduced
642
Closed
83

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$231M
2
GILD icon
Gilead Sciences
GILD
+$113M
3
PCG icon
PG&E
PCG
+$102M
4
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$80.2M
5
ALL icon
Allstate
ALL
+$64.4M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$472M
2
ABBV icon
AbbVie
ABBV
+$121M
3
VLUE icon
iShares MSCI USA Value Factor ETF
VLUE
+$69.5M
4
CRM icon
Salesforce
CRM
+$64.3M
5
HD icon
Home Depot
HD
+$62.4M

Sector Composition

Rank Sector Weight
1 Technology 20.24%
2 Healthcare 19.03%
3 Financials 13.02%
4 Consumer Discretionary 9.39%
5 Industrials 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RYTM icon
1751
Rhythm Pharmaceuticals
RYTM
$7.41B
$274K ﹤0.01%
11,170
-18,175
-62% -$338K
BDN
1752
Brandywine Realty Trust
BDN
$521M
$273K ﹤0.01%
40,500
LPG icon
1753
Dorian LPG
LPG
$1.9B
$271K ﹤0.01%
19,990
+8,130
+69% +$122K
VIRX
1754
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$271K ﹤0.01%
63,406
ELME
1755
Elme Communities
ELME
$142M
$270K ﹤0.01%
15,380
DNUT icon
1756
Krispy Kreme
DNUT
$564M
$268K ﹤0.01%
23,280
+21,970
+1,677% +$289K
PETS icon
1757
PetMed Express
PETS
$43M
$268K ﹤0.01%
13,727
PLUS icon
1758
ePlus
PLUS
$2.42B
$268K ﹤0.01%
6,450
AWI icon
1759
Armstrong World Industries
AWI
$7.62B
$264K ﹤0.01%
+3,330
New +$282K
BLFS icon
1760
BioLife Solutions
BLFS
$1.56B
$264K ﹤0.01%
11,590
-1,340
-10% -$28.7K
OII icon
1761
Oceaneering
OII
$4.78B
$264K ﹤0.01%
33,200
-6,330
-16% -$59.5K
VIPS icon
1762
Vipshop
VIPS
$7.13B
$264K ﹤0.01%
31,400
-600
-2% -$5.97K
GRTX
1763
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$264K ﹤0.01%
151,777
ROCC
1764
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$264K ﹤0.01%
+8,410
New +$296K
AMWL icon
1765
American Well
AMWL
$185M
$263K ﹤0.01%
3,677
+31
+0.9% +$2.71K
CHCT
1766
Community Healthcare Trust
CHCT
$543M
$263K ﹤0.01%
8,030
IRWD icon
1767
Ironwood Pharmaceuticals
IRWD
$626M
$262K ﹤0.01%
+25,250
New +$286K
NTST
1768
NETSTREIT Corp
NTST
$2.13B
$262K ﹤0.01%
+14,710
New +$294K
PACB icon
1769
Pacific Biosciences
PACB
$432M
$262K ﹤0.01%
45,150
AI icon
1770
C3.ai
AI
$1.38B
$261K ﹤0.01%
20,890
+10,380
+99% +$186K
DMC
1771
Del Monte Corp
DMC
$1.37B
$260K ﹤0.01%
11,200
QURE icon
1772
uniQure
QURE
$2.52B
$259K ﹤0.01%
13,800
RCUS icon
1773
Arcus Biosciences
RCUS
$3.4B
$258K ﹤0.01%
9,880
HZO icon
1774
MarineMax
HZO
$782M
$256K ﹤0.01%
8,607
KRYS icon
1775
Krystal Biotech
KRYS
$10.7B
$256K ﹤0.01%
+3,670
New +$265K

Similar funds

Ensign Peak Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Ensign Peak Advisors held 2,393 positions worth $40.3B, down 4.3% from $42.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Ensign Peak Advisors's Q3 2022 filing shows 237 new, 785 increased, 642 reduced and 83 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M. The largest sale was Visa, an estimated $472M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q3 2022 buy was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M.
  • Ensign Peak Advisors added most to Mastercard in Q3 2022, an estimated $231M increase.
  • Ensign Peak Advisors's biggest Q3 2022 reduction was AbbVie, cutting an estimated $121M.
  • Ensign Peak Advisors fully exited Visa in Q3 2022, selling an estimated $472M.
  • Ensign Peak Advisors's ten largest holdings make up 25% of its $40.3B portfolio in Q3 2022.
  • Ensign Peak Advisors opened 237 new positions and closed 83 in Q3 2022.
  • Ensign Peak Advisors's portfolio value fell 4.3% quarter-over-quarter to $40.3B.

Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.